Dr Reddys Laboratories Share Price Today - Live Blog for September 09, 2025

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.26% gain, with the share price now at ₹1,292.80. Notably, the stock's PE ratio stands at 18.6400, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd share price surged by 0.26%. With its current market price standing at ₹1,292.80 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,289.50, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's shares experienced a 0.05% uptick, and they are currently valued at ₹1,289.50, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.02% in its share price, and it currently trades at ₹1,288.20 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.03%, reaching a current market price of ₹1,288.50. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a notable 0.37% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,287.30. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.20% boost, with the current market value at ₹1,282.15 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.19% decline, and it currently trades at ₹1,279.55 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.03% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,282.00 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.08% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,280.85 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, a situation worth noting. At present, the stock is trading at ₹1,279.85. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.6400, while the industry PE ratio is 34.7168.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.09% increase and currently trading at ₹1,280.00 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd experienced a -0.12% downturn in its share price, and it's currently trading at ₹1,279.50. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.47% uptick in its share price. As a result, it's now actively trading at ₹1,281.00 per share, making it an attractive option for investors.

The stock of Dr Reddys Laboratories Ltd is facing a -0.06% decline and is currently trading at ₹1,275.95 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd share price has declined by -0.19%, and it's currently trading at ₹1,276.60. The stock maintains a PE of 18.6400, while the industry PE is 34.7168, prompting discussions about its valuation.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.02% boost, with the current market value at ₹1,278.40 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.12% upswing, and it's currently trading at ₹1,278.15 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd share price has declined by -0.24%, and it's currently trading at ₹1,276.65. The stock maintains a PE of 18.6400, while the industry PE is 34.7168, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.18% uptick in its share price. As a result, it's now actively trading at ₹1,279.75 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.11% uptick in its share price. As a result, it's now actively trading at ₹1,277.95 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.26%, and as of now, it's trading at ₹1,276.00 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd experienced a substantial 0.14% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,274.50, making it an appealing option for investors.

Dr Reddys Laboratories Ltd witnessed a notable 0.14% surge in its share price and is presently trading at ₹1,274.50, captivating the attention of market participants.

Following a noteworthy 0.07% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,273.00. When it comes to valuation, this stock has a PE ratio of 18.6400, with the industry PE ratio at 34.7168.

Dr Reddys Laboratories Ltd witnessed a notable 1.91% surge in its share price and is presently trading at ₹1,278.00, captivating the attention of market participants.